tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Pliant Therapeutics price target raised to $1.70 from $1.50 at Citi
PremiumThe FlyPliant Therapeutics price target raised to $1.70 from $1.50 at Citi
2M ago
Pliant Therapeutics price target lowered to $4 from $17 at Piper Sandler
Premium
The Fly
Pliant Therapeutics price target lowered to $4 from $17 at Piper Sandler
2M ago
Pliant Therapeutics reports Q2 EPS (71c), consensus (68c)
Premium
The Fly
Pliant Therapeutics reports Q2 EPS (71c), consensus (68c)
3M ago
Pliant Therapeutics Reports Q1 2025 Financial Results
PremiumCompany AnnouncementsPliant Therapeutics Reports Q1 2025 Financial Results
6M ago
Pliant Therapeutics reports Q1 EPS (92c), consensus (62c)
Premium
The Fly
Pliant Therapeutics reports Q1 EPS (92c), consensus (62c)
6M ago
Pliant Therapeutics reports Q1 EPS (92c), consensus (75c)
Premium
The Fly
Pliant Therapeutics reports Q1 EPS (92c), consensus (75c)
6M ago
Pliant Therapeutics announces interim Phase 1 data from PLN-101095
PremiumThe FlyPliant Therapeutics announces interim Phase 1 data from PLN-101095
7M ago
Pliant Therapeutics Adopts Stockholder Rights Agreement
Premium
Company Announcements
Pliant Therapeutics Adopts Stockholder Rights Agreement
7M ago
Pliant Therapeutics adopts limited duration stockholder rights agreement
Premium
The Fly
Pliant Therapeutics adopts limited duration stockholder rights agreement
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100